These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23069206)

  • 21. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
    Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
    Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recipient immune repertoire and engraftment site influence the immune pathway effecting acute hepatocellular allograft rejection.
    Horne PH; Lunsford KE; Walker JP; Koester MA; Bumgardner GL
    Cell Transplant; 2008; 17(7):829-44. PubMed ID: 19044209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for tissue-directed immune responses: analysis of CD4- and CD8-dependent alloimmunity.
    Lunsford KE; Gao D; Eiring AM; Wang Y; Frankel WL; Bumgardner GL
    Transplantation; 2004 Oct; 78(8):1125-33. PubMed ID: 15502708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-suppressor CD8+ T Cells Require CXCR5.
    Zimmerer JM; Ringwald BA; Elzein SM; Avila CL; Warren RT; Abdel-Rasoul M; Bumgardner GL
    Transplantation; 2019 Sep; 103(9):1809-1820. PubMed ID: 30830040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44/CD70 blockade and anti-CD154/LFA-1 treatment synergistically suppress accelerated rejection and prolong cardiac allograft survival in mice.
    Shao W; Yan G; Lin Y; Chen J; Dai H; Wang F; Xi Y; Thorlacius H; Qi Z
    Scand J Immunol; 2011 Nov; 74(5):430-7. PubMed ID: 21707692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T Cells.
    Han JL; Zimmerer JM; Zeng Q; Chaudhari S; Satoskar A; Abdel-Rasoul M; Uwase H; Breuer CK; Bumgardner GL
    J Immunol; 2024 May; 212(9):1504-1518. PubMed ID: 38517294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.
    Ferrer IR; Wagener ME; Song M; Ford ML
    PLoS One; 2012; 7(7):e40559. PubMed ID: 22792369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.
    Bumgardner GL; Orosz CG
    Immunol Rev; 2000 Apr; 174():260-79. PubMed ID: 10807522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparate primary and secondary allospecific CD8+ T cell cytolytic effector function in the presence or absence of host CD4+ T cells.
    Horne PH; Koester MA; Jayashankar K; Lunsford KE; Dziema HL; Bumgardner GL
    J Immunol; 2007 Jul; 179(1):80-8. PubMed ID: 17579024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective alloreactive CD8 T cell function and memory response in allograft recipients in the absence of CD4 help.
    Zhai Y; Wang Y; Wu Z; Kupiec-Weglinski JW
    J Immunol; 2007 Oct; 179(7):4529-34. PubMed ID: 17878349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
    Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
    Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
    Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
    J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
    Chen Y; Heeger PS; Valujskikh A
    J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
    Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
    Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ICOS-Dependent and -independent functions of memory CD4 T cells in allograft rejection.
    Zhang QW; Rabant M; Schenk A; Valujskikh A
    Am J Transplant; 2008 Mar; 8(3):497-506. PubMed ID: 18294146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.